<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd"><ep-patent-document id="EP0863756A1" file="EP96939977NWA1.xml" lang="fr" doc-number="0863756" date-publ="19980916" kind="A1" country="EP" status="n" dtd-version="ep-patent-document-v1-4"><SDOBI lang="fr"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSE..PTIE......FI..........................................................</B001EP><B003EP>*</B003EP><B007EP>EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)</B007EP></eptags></B000><B100><B110>0863756</B110><B130>A1</B130><B140><date>19980916</date></B140><B190>EP</B190></B100><B200><B210>96939977.0</B210><B220><date>19961126</date></B220><B240><B241><date>19980514</date></B241></B240><B250>fr</B250><B251EP>fr</B251EP><B260>fr</B260></B200><B300><B310>19950014240</B310><B320><date>19951201</date></B320><B330><ctry>FR</ctry></B330></B300><B400><B405><date>19980916</date><bnum>199838</bnum></B405><B430><date>19980916</date><bnum>199838</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07D 277/    82            A I                    </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  31/    00            A I                    </text></classification-ipcr><classification-ipcr sequence="3"><text>A61K  31/   425            A I                    </text></classification-ipcr><classification-ipcr sequence="4"><text>A61K  31/   428            A I                    </text></classification-ipcr><classification-ipcr sequence="5"><text>A61P  25/    16            A I                    </text></classification-ipcr></B510EP><B540><B541>en</B541><B542>USE OF 2-IMINOBENZOTHIAZOLINES FOR TREATING PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES</B542><B541>fr</B541><B542>APPLICATION DE 2-IMINOBENZOTHIAZOLINES DANS LE TRAITEMENT DU PARKINSON ET DES SYNDROMES PARKINSONIENS</B542><B541>de</B541><B542>VERWENDUNG VON 2-IMINOBENZOTHIAZOLINE ZUR BEHANDLUNG VON PARKINSON UND PARKINSONARTIGEN SYNDROMEN</B542></B540></B500><B700><B710><B711><snm>RHONE-POULENC RORER S.A.</snm><adr><str>20, avenue Raymond Aron</str><city>92160 Antony</city><ctry>FR</ctry></adr></B711></B710><B720><B721><snm>BOIREAU, Alain</snm><adr><str>80, rue Porchefontaine</str><city>F-94370 Sucy-en-Brie</city><ctry>FR</ctry></adr></B721><B721><snm>DUBROEUCQ, Marie-Christine</snm><adr><str>13, villa de Malleville</str><city>F-95880 Enghein-les-Bains</city><ctry>FR</ctry></adr></B721><B721><snm>IMPERATO, Assunta</snm><adr><str>195 bis, rue Raymond-Losserand</str><city>F-75014 Paris</city><ctry>FR</ctry></adr></B721><B721><snm>JIMONET, Patrick</snm><adr><str>13, avenue de Normandie</str><city>F-78450 Villepreux</city><ctry>FR</ctry></adr></B721><B721><snm>MIGNANI, Serge</snm><adr><str>14, avenue de Robinson</str><city>F-92290 Chatenay-Malabry</city><ctry>FR</ctry></adr></B721><B721><snm>RANDLE, John</snm><adr><str>5, rue Vauthier</str><city>F-92100 Boulogne-Billancourt</city><ctry>FR</ctry></adr></B721></B720></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B860><B861><dnum><anum>FR1996001867</anum></dnum><date>19961126</date></B861><B862>fr</B862></B860><B870><B871><dnum><pnum>WO1997020558</pnum></dnum><date>19970612</date><bnum>199725</bnum></B871></B870></B800></SDOBI></ep-patent-document>